Brexpiprazole
【Chemical Name】Brexpiprazole
【CAS Number】 913611-97-9
【Dosage and Usage】Tablets: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg，used for the treatment of depressive disorder (MDD) in adults and treatment of schizophrenia
一、 Product Overview
Brexpiprazole is a small molecule drug developed by Otsuka and Lundbeck which is Used as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults and treatment of schizophrenia in adults and pediatric patients ages 13 years and older.It was approved by the US Food and Drug Administration (FDA) on Jul. 10, 2015.
二、Main products
Description | Structural Formula | CAS No. | Category |
Brexpiprazole |
| 913611-97-9 | API |
7-hydroxyquinolin-2(1H)-one |
| 70500-72-0 | intermediates |
1-(1-Benzothiophen-4-yl)piperazine hydrochloride |
| 913614-18-3 | intermediates |
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer’s risk.